Stay updated on Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial
Sign up to get notified when there's something new on the Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial page.

Latest updates to the Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial page
- Check6 days agoChange DetectedThe ClinicalTrials.gov record for the selinexor maintenance study in endometrial cancer is now displayed, with details on the study design, eligibility, participating locations, outcomes, and record history.SummaryDifference89%

- Check14 days agoChange DetectedThe site footer’s revision identifier changed from v3.7.2 to v3.8.0.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedAn NIH-wide notice about terminology changes appeared, and the site revision label changed from v3.7.1 to v3.7.2. The clinical-trial record remains unavailable behind a 403 error.SummaryDifference1%

- Check42 days agoChange DetectedThe footer’s site revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check55 days agoChange DetectedThe study page now shows a 403 Forbidden error, replacing the previous study details and navigation. This blocks access to the core content of the record, preventing users from viewing study information and related data.SummaryDifference18%

- Check63 days agoChange DetectedThe page's revision number was updated from v3.6.6 to v3.7.0, indicating an internal update to the record. No changes to visible content or study information are described.SummaryDifference0.0%

Stay in the know with updates to Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Selinexor vs Placebo Maintenance Post-Chemo in Endometrial Ca Clinical Trial page.